Medical Devices Fda Faces Challenges In Conducting Inspections Of Foreign Manufacturing Establishments
Medical Devices Fda Faces Challenges In Conducting Inspections Of Foreign Manufacturing Establishments Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Medical Devices Fda Faces Challenges In Conducting Inspections Of Foreign Manufacturing Establishments book. This book definitely worth reading, it is an incredibly well-written.
Medical Devices: FDA Faces Challenges in Conducting Inspections of Foreign Manufacturing Establishments by Marcia Crosse Pdf
As part of the FDA oversight of the safety and effectiveness of medical devices marketed in the U.S., it inspects certain foreign and domestic establishments where these devices are manufactured. To help FDA address shortcomings in its inspection program, the Medical Device User Fee and Modernization Act of 2002 required FDA to accredit third parties to inspect certain establishments. In response, FDA has implemented two voluntary programs for that purpose. This statement assesses: (1) FDA¿s program for inspecting foreign establishments that manufacture medical devices for the U.S. market; and (2) FDA¿s programs for third-party inspections of those establishments.
Marcia Crosse,United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations,United States. Government Accountability Office
Author : Marcia Crosse,United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations,United States. Government Accountability Office Publisher : Unknown Page : 26 pages File Size : 54,7 Mb Release : 2008 Category : Electronic ISBN : OCLC:406819530
Medical Devices by Marcia Crosse,United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations,United States. Government Accountability Office Pdf
Medical Devices: Challenges for FDA in Conducting Manufacturer Inspections by Marcia Crosse Pdf
As part of the FDA¿s oversight of the safety & effectiveness of medical devices marketed in the U.S., it inspects domestic & foreign establishments where these devices are manufactured. To help FDA address shortcomings in its inspection program, the Medical Device User Fee & Modernization Act of 2002 required FDA to accredit third parties to inspect certain establishments. In response, FDA has implemented two such voluntary programs. This statement: (1) assesses FDA¿s mgmt. of inspections of establishments -- particularly those in foreign countries -- manufacturing devices for the U.S. market; & (2) provides the status of FDA¿s programs for third-party inspections of medical device manufacturing establishments. Illustrations.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations Publisher : Unknown Page : 268 pages File Size : 47,7 Mb Release : 2008 Category : Business & Economics ISBN : UOM:39015085459595
FDA's Foreign Drug Inspection Program by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations Pdf
Discussion Draft of the Food and Drug Administration Globalization Act Legislation: Device and Cosmetic Safety Provisions, Serial No. 110-117, May 14, 2008, 110-2 Hearing, * by Anonim Pdf
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Publisher : Unknown Page : 240 pages File Size : 55,7 Mb Release : 2008 Category : Cosmetics ISBN : UOM:39015085459587
Discussion Draft of the Food and Drug Administration Globalization Act Legislation by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Pdf
Medical Devices: Shortcomings in FDA's Premarket Review, Postmarket Surveillance, and Inspections of Device Manufacturing Establishments by Marcia Crosse Pdf
Americans depend on FDA to provide assurance that medical devices (MD) sold in the U.S. are safe and effective. FDA classifies MD types into 3 classes, with class I: those with the lowest risk to patients (such as forceps) and class III: those with the greatest risk (such as pacemakers). FDA's responsibilities include premarket and postmarket oversight -- spanning, for ex., both premarket review of MD and postmarket surveillance. These responsibilities apply to all devices marketed in the U.S., regardless of whether they are manufactured domestically or overseas. This testimony relates to FDA's responsibilities for MD, including premarket review, postmarket surveillance, and inspection of manufacturing establishments.
Drug Safety: FDA has Conducted More Foreign Inspections and Begun to Improve Its Information on Foreign Establishments, but More Progress Is Needed by Anonim Pdf
Twenty years ago, it was reported that the FDA was concerned that it lacked resources to fulfill its mission, which includes oversight of the safety and effectiveness of medical products -- human drugs, biologics, and medical devices -- marketed for sale in the U.S. Since then, concerns have been raised regarding FDA's ability to meet its oversight responsibilities. This report reviews the resources supporting FDA's medical product oversight responsibilities. It examines trends in: (1) FDA's funding and staffing resources for its medical product oversight responsibilities from FY 1999 through 2008; and (2) FDA's medical product oversight responsibilities during this same period. Charts and tables.
The FDA oversees the safety and effectiveness of human drugs marketed in the U.S., including those manufactured in foreign establishments. FDA inspects foreign establishments in order to ensure that the quality of drugs is not jeopardized by poor manufacturing processes. This report examines: (1) the extent to which FDA has accurate data on the number of foreign establishments subject to inspection; (2) the frequency of foreign inspections; and (3) oversight by FDA to ensure that foreign establishments correct serious problems identified during inspections. The author analyzed info. from FDA databases, reviewed inspection reports which identified serious deficiencies, and interviewed FDA officials. Includes recommendations. Illus.
The FDA relies heavily on info. tech. (IT) to carry out its responsibility for ensuring the safety and effectiveness of certain consumer products. Recognizing limitations in its IT capabilities that had been previously identified, the agency has begun various initiatives to modernize its IT systems. This report: (1) evaluates the FDA¿s overall plans for modernizing its IT systems, including the extent to which the plans address identified limitations or inadequacies in the agency¿s capabilities; and (2) assesses to what extent the agency has put in place key IT mgmt. policies and processes to guide the implementation of its modernization projects. Includes recommendations. Charts and tables.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Publisher : Unknown Page : 112 pages File Size : 46,8 Mb Release : 2012 Category : Medical instruments and apparatus ISBN : MINN:31951D034792315
Two thirds of U.S. adults are overweight, and childhood obesity and diabetes are on the rise. To reverse these health problems, experts are urging Americans to eat healthier. Food labels contain information to help consumers who want to make healthy food choices. The FDA oversees fed. labeling rules for 80 percent of foods. This report examines: (1) FDA's efforts to ensure that domestic and imported foods comply with labeling rules; (2) the challenges FDA faces in these efforts; and (3) the views of key stakeholders on FDA actions needed to mitigate misleading labeling. The auditor analyzed FDA data, reports, and requirements on food labeling oversight and compliance and interviewed agency and key stakeholder group officials. Illus.